OptiBiotix Health (LON:OPTI) Shares Down 10.6% – Should You Sell?

OptiBiotix Health Plc (LON:OPTIGet Free Report) shares fell 10.6% during mid-day trading on Monday . The stock traded as low as GBX 13.01 ($0.18) and last traded at GBX 13.13 ($0.18). 543,027 shares traded hands during mid-day trading, an increase of 84% from the average session volume of 295,713 shares. The stock had previously closed at GBX 14.68 ($0.20).

OptiBiotix Health Trading Down 10.6%

The stock’s 50 day moving average is GBX 17.25 and its 200-day moving average is GBX 17.15. The company has a market cap of £12.86 million, a P/E ratio of -4.15 and a beta of 1.71.

OptiBiotix Health Company Profile

(Get Free Report)

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements.

Further Reading

Receive News & Ratings for OptiBiotix Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health and related companies with MarketBeat.com's FREE daily email newsletter.